BioViva USA Inc™
  • HOME
  • OUR TEAM
  • Invest
  • Intellectual Property
  • Ethos
  • Contact us
BioViva USA Inc™
  • HOME/
  • OUR TEAM/
  • Invest/
  • Intellectual Property /
  • Ethos/
  • Contact us/
blog-banner-min.png
BioViva USA Inc™

The Cure is in the Helix of Humanity

Blog

Press releases, updates and original articles

BioViva USA Inc™
  • HOME/
  • OUR TEAM/
  • Invest/
  • Intellectual Property /
  • Ethos/
  • Contact us/
March 08, 2018

Overexpression of genes to suppress dsRNA innate immunity

March 08, 2018/ Liz Parrish
600px-Humanstemcell.jpg

BioViva scientist Ali Fallah et al have worked on the reprogramming potential of GCS (germline derived stem cells) the self-renewal capacity of which makes them a good source for research and clinical use, and shown that their innate immunity can be manipulated via overexpression of three key genes.

 

Source: NCBI Pub Med

March 08, 2018/ Liz Parrish/ Comment

Liz Parrish

  • BioViva’s aims to be an advanced ...
  • What’s All The Buzz? BioViva’s ...

We are leaders in gene therapy innovation, developing advanced platforms designed to address severe genetic disorders and the underlying mechanisms of cellular aging.

Join Our Newsletter

Thank you!

©2026. BioViva All rights reserved | For any inquires, contact info@bioviva-science.com